The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Open accessAbstract
Purpose: There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods: We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results: Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion: Clinical benefits were associated with symptom self-reporting during cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“generate a real-time alert notification sent to the patient's cancer care team, based on prior research.25”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which have demonstrated improved symptom control, quality of life, and survival when structured symptom reporting is coupled with clinician response [3,4,7]”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Electronic patient-reported outcome (ePRO) systems have demonstrated that symptom monitoring with clinician response improves symptom control and survival [3,4].”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“The findings of this evaluation are consistent with prior trials of ePRO monitoring”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,957
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. F. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 932
Snyder, C., Aaronson, N., Choucair, A., Elliott, T. E., Greenhalgh, J., Halyard, M., Hess, R., Miller, D. M., Reeve, B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 808
Chen, J., Ou, L., & Hollis, S. J. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-211 · Cited by 796
Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., & Alonso, J. (2008) · Quality of Life Research · doi:10.1007/s11136-007-9295-0 · Cited by 775
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Leahy, A. B., Sit, L., Fruscione, M., Appawu, M., Iasonos, A. E., Atkinson, T. M., Goldfarb, S. B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 622
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,001
Sprave, T., Pfaffenlehner, M., Stoian, R., Christofi, E., Rühle, A., Zöller, D., Fabian, A., Fahrner, H., Binder, H., Schäfer, H. S., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/46189 · Cited by 23
“Additionally, 2 randomized clinical trials [15,16] have demonstrated improved overall survival through PROM telemonitoring in patients with advanced non–small cell lung cancers and metastatic tumor diseases.”
Fontaine, G., Poitras, M.-È., Sasseville, M., Pomey, M., Ouellet, J., Brahim, L. O., Wasserman, S., Bergeron, F., & Lambert, S. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02512-5 · Cited by 23
“…illnesses; they can increase charting of patients’ needs [3], and improve patient-clinician communication [3–5], which in turn can lead to improved symptom management [4–6], thereby improving patients’ quality of life, reducing health care utilization [5], and increasing survival rates [7].”
BackgroundUsability of an online application for reporting the burden of side effects in cancer patients
van Eenbergen, M. C. H. J., van den Hurk, C. J. G., Mols, F., & van de Poll-Franse, L. V. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-4639-1 · Cited by 23
Brooks, G. A., Uno, H., Bowles, E. J. A., Menter, A. R., O'Keeffe-Rosetti, M. C., Tosteson, A. N. A., Ritzwoller, D. P., & Schrag, D. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00147 · Cited by 26
“A number of cancer-focused delivery system innovations have shown promise for reducing hospitalizations during cancer treatment, including patient navigation programs,(10) proactive telephonic nursing,(11) and electronic systems for between-visit symptom reporting.(6,12) Many of these interventions are resource intens…”
BackgroundSelf-citationMercier, C., Dirix, P. R., Ost, P., Billiet, C., Joye, I., Vermeulen, P. B., Lievens, Y. N., & Verellen, D. (2019) · BMC Cancer · doi:10.1186/s12885-019-6097-z · Cited by 23
Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients
Working Group ActEIO Project, Sarrió, R. G., Calsina-Berna, A., García, A. G., Esparza-Miñana, J. M., Ferrer, E. F., & Porta-Sales, J. (2021) · BMC Palliative Care · doi:10.1186/s12904-020-00693-z · Cited by 23
Seventer, E. V., Marquardt, J. P., Troschel, A. S., Best, T. D., Horick, N., Azoba, C. C., Newcomb, R. A., Roeland, E. J., Rosenthal, M. H., Bridge, C. P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7618 · Cited by 22
The Importance of Shared Decision-Making for Patients with Glioblastoma
Musella, A., DeVitto, R., Anthony, M., & Mydland, D. E. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s314792 · Cited by 23
“Conclusions The benefits of SDM are well documented.(1,2) For HCPs, they include improved quality of care and increased patient satisfaction.”
BackgroundInfluentialKuklinski, D., Marques, C. J., Bohlen, K., Westphal, K. C., Lampe, F., & Geißler, A. (2022) · Journal of Orthopaedics · doi:10.1016/j.jor.2022.01.002 · Cited by 23
Donovan, H. S., Sereika, S. M., Wenzel, L. B., Edwards, R. P., Knapp, J. E., Hughes, S. H., Roberge, M. C., Thomas, T. H., Klein, S. J., Spring, M. B., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.00656 · Cited by 23
“A web-based trial of symptommonitoring with automated symptom severity alerts to clinicians improved symptoms, QOL, and survival compared with usual care.(11,12) A systematic review of web-based interventions for cancer-related symptom management identified elements such as symptom monitoring, facilitated communicatio…”
BackgroundResultEnhancing Patient-Centered Surgical Care With Mobile Health Technology
Panda, N., Perez, N. P., Tsangaris, E., Edelen, M. O., Pusic, A. L., Zheng, F., & Haynes, A. B. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.01.005 · Cited by 23
Oswald, L. B., Li, X., Carvajal, R., Hoogland, A. I., Gudenkauf, L. M., Hansen, D. K., Alsina, M., Locke, F. L., Rodriguez, Y., Irizarry-Arroyo, N. E., et al. (2022) · Cancers · doi:10.3390/cancers14112742 · Cited by 23
Lombi, L., Alfieri, S., & Brunelli, C. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102283 · Cited by 22
Zannad, F. M., Alikhaani, J. D., Alikhaani, S., Butler, J., Gordon, J. P., Jensen, K., Khatib, R., Mantovani, L. G., Martinez, R., Moore, W., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2828 · Cited by 24
Hyland, C. J., Mou, D., Virji, A. Z., Sokas, C. M., Bokhour, B. G., Pusic, A. L., & Mjåset, C. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03388-z · Cited by 23
Peipert, J. D., Zhao, F., Lee, J., Shen, S., Ip, E. H., O'Connell, N. S., Carlos, R. C., Graham, N., Smith, M. L., Gareen, I. F., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3854 · Cited by 23
Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out
Renovanz, M., Hechtner, M., Kohlmann, K., Janko, M., Nadji‐Ohl, M., Singer, S., Ringel, F. A., Coburger, J., & Hickmann, A. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npx026 · Cited by 23
Knoerl, R., Chornoby, Z., & Smith, E. (2018) · Pain Management Nursing · doi:10.1016/j.pmn.2018.01.001 · Cited by 23
Giesinger, J. M., Loth, F. L. C., Aaronson, N. K., Arrarás, J. I., Caocci, G., Efficace, F., Grøenvold, M., van Leeuwen, M., Petersen, M. A., Ramage, J. K., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.09.028 · Cited by 25
Jibb, L., Nathan, P. C., Breakey, V. R., Fernandez, C. V., Johnston, D. L., Lewis, V. A., McKillop, S. J., Patel, S., Sabapathy, C. A., Strahlendorf, C., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037251 · Cited by 23
Chérrez-Ojeda, I., Bousquet, J., Giménez‐Arnau, A. M., Godse, K. V., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., Allenova, A., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.050 · Cited by 22
Improving attribution of adverse events in oncology clinical trials
George, G. C., Barata, P. C., Campbell, A., Chen, A. P., Cortes, J. E., Hyman, D. M., Jones, L., Karagiannis, T., Klaar, S., Le‐Rademacher, J. G., et al. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.04.004 · Cited by 23
Self-citationTranslation of Patient-Reported Outcomes in Oncology Clinical Trials to Everyday Practice
Ivatury, S. J., Hazard-Jenkins, H. W., Brooks, G. A., McCleary, N. J., Wong, S. L., & Schrag, D. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07749-2 · Cited by 22
Self-citationRenovanz, M., Hickmann, A., Nadji‐Ohl, M., Keric, N., Weimann, E., Wirtz, C. R., Singer, S., Ringel, F. A., & Coburger, J. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05354-8 · Cited by 22
Billingy, N. E., Tromp, V. N. M. F., Veldhuijzen, E., Belderbos, J. S. A., Aaronson, N. K., Feldman, E., Hoek, R. J. A., Bogaard, H. J., Onwuteaka-Philipsen, B. D., van de Poll-Franse, L. V., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052494 · Cited by 23
Lopes, A. M. D. S., Colomer‐Lahiguera, S., Mederos, N., Aedo-Lopez, V., Spurrier‐Bernard, G., Tolstrup, L. K., Pappot, H., Aspeslagh, S., Rogiers, A., Neyns, B., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.026 · Cited by 23
“Their use in clinical trials to track symptomatic toxicities of cancer treatments can improve the management of those symptoms, thereby preserving the health-related quality of life, and allowing patients to remain in treatment for longer, and decreasing emergency department visits [12,13].”
BackgroundViitala, A., Åstedt-Kurki, P. M., Lehto, J. T., & Palonen, M. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.102047 · Cited by 22
The Symptom Experience in Pediatric Cancer: Current Conceptualizations and Future Directions
Jibb, L., Ameringer, S., Macpherson, C. F., & Sivaratnam, S. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01222-2 · Cited by 22
Suchodolska, G., & Senkus, E. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102364 · Cited by 27
Farina, E. G., Rowell, J., Revette, A. C., Haakenstad, E. K., Cleveland, J. L. F., Allende, R., Hassett, M. J., Schrag, D., & McCleary, N. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.23898 · Cited by 22
“The subjects listed were (1) activity tracker; (2) medication schedule with reminders; (3) medication tracking system; (4) symptom reporter; (5) symptom educational library; (6) communication tool; and (7) calendar for medical appointments.”
BackgroundSelf-citationKiderlen, T. R., Schnack, A., & de Wit, M. (2022) · Journal of Public Health · doi:10.1007/s10389-022-01767-3 · Cited by 22
“Measureable clinical outcome benefits included enhanced health-related quality of life (Basch et al. 2016), earlier detection of relapse (Denis et al. 2014), decrease in hospital admission (Basch et al. 2016), and prolonged survival (Basch et al. 2016; Denis et al. 2019).”
BackgroundResultInfluentialBreidenbach, C., Kowalski, C., Sibert, N. T., Hagemeier, A., Roth, R., Wesselmann, S., Seufferlein, T. T. W., Benz, S. R., Post, S., Siegel, R., et al. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0325 · Cited by 22
Bae, W. K., Kwon, J., Lee, H. W., Lee, S., Song, E., Shim, H., Ryu, K. H., Song, J.-M., Seo, S., Yang, Y., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4232-z · Cited by 22
Wen, F.-H., Chen, J.-S., Chou, W.-C., Hsieh, C.-H., Chang, W.-C., Shen, W.-C., & Tang, S. (2018) · Psycho-Oncology · doi:10.1002/pon.4775 · Cited by 20
Technology Applications: Use of Digital Health Technology to Enable Drug Development
Liu, J. F., Lee, J., Strock, E. S., Phillips, R., Mari, K., Killiam, B., Bonam, M., Milenkova, T., Kohn, E. C., & Ivy, S. P. (2018) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00153 · Cited by 22
Patient-reported outcomes with nivolumab in advanced solid cancers
Tykodi, S. S., Schadendorf, D., Cella, D. F., Reck, M., Harrington, K. J., Wagner, S., & Shaw, J. W. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.001 · Cited by 23
The effect of treatment on patient‐reported distress after breast cancer diagnosis
Fayanju, O. M., Yenokyan, K., Ren, Y., Goldstein, B. A., Stashko, I., Power, S., Thornton, M., Marcom, P. K., & Hwang, E. S. (2019) · Cancer · doi:10.1002/cncr.32174 · Cited by 21
Albaba, H., Barnes, T. A., Veitch, Z. W. N., Brown, M. C., Shakik, S., Su, S., Naik, H., Wang, T., Liang, M., Cosio, A. P., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0830 · Cited by 22
Lively, A., Minard, L. V., Scott, S., Deal, H., Lambourne, T., & Giffin, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228571 · Cited by 22
Zhang, X., Sun, S., Jiangenuer, L., Zhao, P., Lei, H., Xu, Z. Q., & Wang, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.016 · Cited by 26
Kumar, R. R., Sporn, K., Paladugu, P., Khanna, A., Gowda, C., Ngo, A., Waisberg, E., Ong, J., Jagadeesan, R., & Tavakkoli, A. (2025) · Diagnostics · doi:10.3390/diagnostics15131648 · Cited by 22
“Practically, PROMs have shown to streamline data collecting, lower administrative load, and make possible instantaneous scoring and visualization through electronic administration on tablets, cellphones, or web-based platforms [168].”
Use of a symptom diary during chemotherapy: A mixed-methods evaluation of the patient perspective
Coolbrandt, A., Steffens, E., Wildiers, H. P. M. W., Bruyninckx, E., Verslype, C., & Milisen, K. (2017) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2017.09.003 · Cited by 21
Advancing Oncology Nursing Practice Through the Adoption of Patient Monitoring Digital Tools
Wilson, C. M., & Mooney, K. H. (2020) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2020.151087 · Cited by 24
“3,7,8 This system has undergone many iterations to develop all of the components to the system, and has proven to be effective and efficient at addressing patient chemotherapy symptom management needs at home resulting in a symptom burden reduction of 3.59 severity points (1–10 scale) which is a…”
BackgroundInfluentialHough, S. M., McDevitt, R. L., Nachar, V. R., Kraft, S. L., Brown, A. M., Christen, C., Frame, D. G., & Smerage, J. B. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00639 · Cited by 21
“In addition, PROs for cancer symptom management have led to a positive impact on patient outcomes, including improved overall survival.(14)”
BackgroundJohnson, P. C., Bhatt, S. M., Reynolds, M. J., Dhawale, T. M., Ufere, N. N., Jagielo, A. D., Lavoie, M. W., Topping, C. E. W., Clay, M. A., Rice, J., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.02.029 · Cited by 22
Lee, M., Kang, D., Kim, S., Lim, J., Yoon, J., Kim, Y., Shim, S., Kang, E., Ahn, J. S., Cho, J., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06473-6 · Cited by 22
Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
Zhang, L., & Lu, Y. (2021) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon-2129 · Cited by 21
“[58] Furthermore, Basch et al.[59] found that ePRO used in the management of cancer patients lead to a better QoL, fewer emergency room visits and hospitalizations, a longer duration of palliative chemotherapy, and superior quality‑adjusted survival in the patients.”
MethodVardy, J. L., Liew, A., Warby, A., Elder, A., Keshet, I., Devine, R. J., Ouliaris, C., Renton, C., Tattersall, M. H. N., & Dhillon, H. M. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06804-1 · Cited by 21
“This is likely because many health care professionals focus more on physical side-effects when providing information and obtaining informed consent prior to chemotherapy [17] and in eliciting symptoms in subsequent consultations [18, 19].”
BackgroundYu, Q., Yu, H., Xu, W., Pu, Y., Nie, Y., Dai, W., Wei, X., Wang, X. S., Cleeland, C. S., Li, Q., et al. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s348633 · Cited by 21
“Recently, several investigators have demonstrated that using a web-based symptom monitoring system can reduce symptom burden and improve the overall survival of patients with advanced cancer.(24,25) This process is done through a mechanism that using the weekly PRO assessment of index symptoms with an alert threshold…”
BackgroundDzimitrowicz, H. E., Blakely, L. J., Jones, L. W., & LeBlanc, T. W. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_350550 · Cited by 21
Fraterman, I., Glaser, S. L. C., Wilgenhof, S., Medlock, S. K., Mallo, H. A., Ronald Cornet, A., van de Poll-Franse, L. V., & Boekhout, A. H. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07133-z · Cited by 21
Parikh, R. B., Hasler, J., Zhang, Y., Liu, M., Chivers, C., Ferrell, W. J., Gabriel, P. E., Lerman, C. E., Bekelman, J. E., & Chen, J. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00073 · Cited by 25
“Routine PRO assessment is now more common and may allow oncology clinicians to better identify patients with high symptom burden or declining functional status.(22-26) However, the role of PROs in risk stratification remains unexplored.”
BackgroundManagement of Patients With Pancreatic Cancer Using the “Right Track” Model
Rosenzweig, A., Berlin, J. D., Chari, S. T., Kindler, H. L., Matrisian, L. M., Mayoral, A., Mills, J. B., Nissen, N. N., Picozzi, V. J., Zelada-Arenas, F., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad080 · Cited by 20
Stoller, S., Capozza, S. J., Alberti, P., Lustberg, M. B., & Kleckner, I. R. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07734-2 · Cited by 27
“This framework thematically extends prior practice-changing research on the benefits of using early palliative care [81, 83, 83] and the benefits of reporting patient symptoms [84] to improve patient care and quality of life.”
BackgroundChallenges of caring for older patients with multimorbidity including cancer
Seghers, P. A. L., Rostoft, S., O’Hanlon, S., O'Sullivan, B., Portielje, J. E. A., Wildiers, H. P. M. W., Soubeyran, P., & Hamaker, M. E. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101588 · Cited by 21
Lai-Kwon, J. E., Rutherford, C., Jefford, M., Gore, C., & Best, S. (2024) · JCO Oncology Practice · doi:10.1200/op.23.00462 · Cited by 21
Sterba, K. R., Zapka, J. G., LaPelle, N. R., Garris, T. K., Buchanan, A., Scallion, M. L., & Day, T. A. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0621-4 · Cited by 21
“Evidence is increasing concerning the benefits of incorporating automated patient-reported outcome assessment systems into clinical practice with effective programs to train clinicians to use these systems [25, 40, 41].”
BackgroundHead and Neck Cancer: Improving Patient-Reported Outcome Measures for Clinical Practice
Silveira, A., Monteiro, E. F., & Sequeira, T. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0578-1 · Cited by 24
Survivorship care planning and implementation in neuro-oncology
Leeper, H. E., & Milbury, K. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy110 · Cited by 21
Girgis, A., Durcinoska, I., Arnold, A., & Delaney, G. P. (2019) · Medical Care · doi:10.1097/mlr.0000000000001094 · Cited by 21
Pathway to Precision Patient-Reported Outcomes
Kaufmann, T. L., & Rocque, G. B. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.02163 · Cited by 22
Roberts, K. E., Adsett, I. T., Rickett, K., Conroy, S. M., Chatfield, M. D., & Woodward, N. E. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013167.pub2 · Cited by 25
Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items
Taarnhøj, G. A., Kennedy, F., Absolom, K. L., Bæksted, C., Vogelius, I. R., Johansen, C., Velikova, G., & Pappot, H. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.05.017 · Cited by 21
“3 Introduction Within the last decade health-related quality of life (HRQO L) has become an integral part of clinical studies, usually as a secondary endpoint, or as a primary endpoint evaluati on of palliative treatments (1-6).”
BackgroundMethodBasch, E., Charlot, M., & Dueck, A. C. (2020) · Cancer Medicine · doi:10.1002/cam4.3480 · Cited by 20
Self-citationDoolin, J. W., Berry, J. L., Forbath, N. S., Tocci, N. X., Dechen, T., Li, S., Hartwell, R. A., Espiritu, J. K., Roberts, D. A., Zerillo, J. A., et al. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00191 · Cited by 20
Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide
Lai-Kwon, J. E., Thorner, E. D., Rutherford, C., Crossnohere, N. L., & Brundage, M. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438512 · Cited by 21
Harnessing the Power of Patient-Reported Outcomes in Oncology
Nipp, R. D., & Temel, J. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0037 · Cited by 20
“Notably, patients' symptoms represent a modifiable risk factor that, if properly managed, can prompt earlier initiation of supportive care measures and may result in better symptom management, decreased health care utilization, and potentially improved survival (3, 5).”
BackgroundThomas, T. H., McLaughlin, M., Hayden, M. A., Shumaker, E., Trybus, J., Myers, E., Zabiegalski, A., & Cohen, S. M. (2019) · Games for Health Journal · doi:10.1089/g4h.2018.0021 · Cited by 20
Dai, W., Zhang, Y., Feng, W., Liao, X., Mu, Y., Zhang, R., Wei, X., Wu, C., Xie, S., Li, Q., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030041 · Cited by 20
Measuring Outcomes in Cosmetic Abdominoplasty
de Vries, C. E. E., Klassen, A. F., Hoogbergen, M. M., Alderman, A. K., & Pusic, A. L. (2020) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2020.03.003 · Cited by 20
Virtual Visits in Oncology: Enhancing Care Quality While Designing for Equity
Lafata, J. E., Smith, A. B., Wood, W. A., Fitzpatrick, B., & Royce, T. J. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00645 · Cited by 19
Stan, D. L., Inselman, J., Ridgeway, J. L., Johnson, K. N., Christopherson, L. A., McColley, S., Brown, J. K., Phillips, S. A., Allen, S. V., Hazelton, J. K., et al. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-01136-1 · Cited by 20
Khan, N. N., Maharaj, A. D., Evans, S., Pilgrim, C. H. C., Zalcberg, J. R., Brown, W. A., Cashin, P., Croagh, D. G., Michael, N. G., Shapiro, J. D., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07625-y · Cited by 21
“In order to enable identification of specific supportive care needs, models of care centred around measurement of patient reported outcomes for symptom monitoring [31] may be beneficial for patients.”
BackgroundVelikova, G., Absolom, K. L., Hewison, J., Holch, P., Warrington, L., AVERY, K. N. L., Richards, H. S., Blazeby, J. M., Dawkins, B., Hulme, C. T., et al. (2022) · Programme Grants for Applied Research · doi:10.3310/fdde8516 · Cited by 21
Thomas, T. H., Go, K., Go, K., McKinley, N. J., Dougherty, K. R., You, K.-L., & Lee, Y. J. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104782 · Cited by 20
Screening for Distress and Health Outcomes in Head and Neck Cancer
Gascon, B., Panjwani, A. A., Mazzurco, O., & Li, M. (2022) · Current Oncology · doi:10.3390/curroncol29060304 · Cited by 20
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Gudenkauf, L. M., Chavez, M., Maconi, M. L., Geiss, C., Seyedroudbari, A., Thin, P., Hoogland, A. I., Nguyen, K., Murthy, V., Armstrong, W. R., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264946 · Cited by 20
“PRO importance is underscored by recent evidence that PRO monitoring improved post-chemother-apy survival and other important outcomes over usual care ( 11,12 ).”
BackgroundKlagholz, S. D., Ross, A. C., Wehrlen, L., Bedoya, S. Z., Wiener, L. S., & Bevans, M. F. (2018) · Psycho-Oncology · doi:10.1002/pon.4658 · Cited by 20
A Method to Summarize Toxicity in Cancer Randomized Clinical Trials
Carbini, M., Suárez‐Fariñas, M., & Maki, R. G. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3314 · Cited by 20
“Given the striking difference of toxicity reported by patients themselves compared with clinician-scored toxicity (24), and the impact of patient-reported toxicity in improving patient outcomes (3), it is clear that the application of this or other methods for calculation of toxicity burden in clinical trials will nee…”
BackgroundMethodGirgis, A., Durcinoska, I., Koh, E., Ng, W. L., Arnold, A., Delaney, G. P., & PROMPT-Care Pathways Working Group (2018) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00024 · Cited by 20
Sztankay, M. J., Neppl, L., Wintner, L. M., Loth, F. L. C., Willenbacher, W., Weger, R., Weyrer, W., Steurer, M., Rumpold, G., & Holzner, B. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13154 · Cited by 19
“Given the importance of HCPs’ feedback for patient adherence and the benefits of routine monitoring for patient care (Basch et al., 2016), it is necessary to raise awareness for the availability of QOL data among healthcare providers.”
BackgroundToward Modernization of Geriatric Oncology by Digital Health Technologies
Shahrokni, A., Loh, K. P., & Wood, W. A. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_279505 · Cited by 18
Trojan, A., Huber, U., Brauchbar, M., & Petrausch, U. (2020) · Case Reports in Oncology · doi:10.1159/000507345 · Cited by 20
Bradford, N., Bowers, A. P., Chan, R. J., Walker, R., Herbert, A., Cashion, C., Condon, P., & Yates, P. M. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000849 · Cited by 20
Zivanovic, O., Chen, L. Y., Vickers, A. J., Straubhar, A. M., Baser, R. E., Veith, M., Aiken, N., Carter, J., Curran, K., Simon, B. A., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.07.004 · Cited by 22
Weisshaar, K., Ewald, H., Halter, J. P., Gerull, S., Schönfeld, S., Senft, Y., Martínez, M. T., Leuppi-Taegtmeyer, A. B., Khanna, N., Maier, B., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01532-3 · Cited by 19
Richter, J. R., Sanchez, L. J., Biran, N., Wang, C. K., Tanenbaum, K., DeVincenzo, V., Grunman, B., Vesole, D. H., Siegel, D. S. D., Pecora, A. L., et al. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.11.021 · Cited by 20
Generalova, O., Roy, M., Hall, E. T., Shah, S. A., Cunanan, K. M., Fardeen, T., Velazquez, B., Chu, G., Bruzzone, B., Cabot, A., et al. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00358-2 · Cited by 20
Role of Patient-Reported Outcomes in Postsurgical Monitoring in Oncology
Smith, A. B., & Basch, E. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.023838 · Cited by 20
Self-citationYildiz Kabak, V., Atasavun Uysal, S., & Duger, T. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05965-1 · Cited by 19
Oakley-Girvan, I., Davis, S. W., Kurian, A., Rosas, L. G., Daniels, J., Palesh, O. G., Mesia, R. J., Kamal, A. H., Longmire, M., & Divi, V. (2021) · JMIR Formative Research · doi:10.2196/22608 · Cited by 17
“For example, in a randomized trial, Basch et al found an increase in health-related quality of life and a decrease in emergency room visits and hospitalizations for survivors who were provided with a tablet computer–based symptom reporting system [10].”
BackgroundInfluentialCancel, M., Sauger, C., Biogeau, J., Dardaine‐Giraud, V., Lecomte, T., Solub, D., Combe, P., Wilmet, R., Aubard, E., Deloigne, A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02150 · Cited by 20
“Basch et al 16 investigated user perceptions of ePRO monitoring during cancer care.”
Core Set of Patient-Reported Outcome Measures for Measuring Quality of Life in Clinical Obesity Care
Dijkhorst, P. J., Monpellier, V. M., Terwee, C. B., Liem, R. S. L., van Wagensveld, B. A., Janssen, I. M. C., Ottosson, J., Halpern, B., Flint, S. W., van Rossum, E. F. C., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07381-4 · Cited by 19
“There is even evidence that PROMs can improve survival in cancer care [33].”
BackgroundPatient- vs Physician-Initiated Response to Symptom Monitoring and Health-Related Quality of Life
Billingy, N. E., van den Hurk, C. J. G., Tromp, V. N. M. F., van de Poll-Franse, L. V., Onwuteaka-Philipsen, B. D., Hugtenburg, J. G., Bogaard, H. J., Belderbos, J. S. A., Aaronson, N. K., Walraven, I., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.28975 · Cited by 20
Who's really in the loop? Rethinking oversight in AI-assisted health care
Abulibdeh, R., Agyemang, G. O., Celi, L. A., Gorijavolu, R., Kalema, N. L., Kleinlein, R., Madapati, K., Salarikia, S. R., & Youssef, A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00204-7 · Cited by 23
Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials
Sedhom, R., FERRELL, B. R., Ruel, N. H., Koczywas, M., Chung, V. M., & Smith, T. J. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa067 · Cited by 19
Wood, W. A., Deal, A. M., Stover, A. M., & Basch, E. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00515 · Cited by 20
“Patients initiating treatment for metastatic breast, genitourinary, gynecologic, or lung cancer were randomly assigned either to serially self-reported symptoms and PS or usual care, to evaluate impact on clinical outcomes.(13,14) This is an ideal trial for the current analysis, as 441 patients and their paired clinic…”
MethodSelf-citationSalvetti, M. D. G., Donato, S. C. T., Machado, C. S. P., de Almeida, N. G., Santos, D. V. D., & Kurita, G. P. (2021) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon_56_20 · Cited by 19
“This is partially due to the rapid response of nurses to patients’ symptoms, which mitigates adverse complications.([39,40]) Loss of appetite in cancer patients is a serious clinical problem and can be related to nausea, changes in the way how food tastes, and metabolic changes associated with the disease and treatmen…”
BackgroundKinjo, T., Kanda, K., & Fujimoto, K. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101956 · Cited by 21
Early Warning Scores and Their Application in the Inpatient Oncology Settings
Nagarajah, S., Krzyzanowska, M. K., & Murphy, T. (2022) · JCO Oncology Practice · doi:10.1200/op.21.00532 · Cited by 19
Metadata
- Authors
- Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children’s Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic,...
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2016-02-20
- Volume
- 34
- Issue
- 6
- Pages
- 557-565
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC4872028
- OpenAlex
- W2195040438
- Cited by
- 2,593
- References
- 36
- Citations by year
- 2026: 252 · 2025: 263 · 2024: 321 · 2023: 288 · 2022: 316 · 2021: 299 · 2020: 292 · 2019: 191 · 2018: 180 · 2017: 143 · 2016: 44
- FWCI
- 53.87
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- Society of Memorial Sloan Kettering
- National Cancer Institute (P30CA008748, P30CA015083, P30CA016086)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- patient-reported outcomes, symptom monitoring, cancer chemotherapy, health-related quality of life, advanced solid tumors, e-mail alerts, emergency department visits, hospitalization, survival, quality-adjusted survival, computer literacy, outpatient oncology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Antineoplastic Agents, Emergency Service, Hospital, Female, Hospitalization, Humans, Male, Middle Aged, Neoplasms, Quality of Life, Survival Rate, Internet, Nurse's Role, Electronic Mail, Self Report, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review